---
schema_version: "secwatch.filing_event.v1"
accession: "0001477449-24-000172"
form_type: "8-K"
ticker: "TDOC"
cik: "0001477449"
company_name: "Teladoc Health, Inc."
filed_at: "2024-07-31T23:59:59+00:00"
generated_at: "2026-05-31T14:25:46.662210+00:00"
event_type: "earnings"
sentiment: "negative"
materiality_score: 0.85
calibrated_materiality_score: 0.85
confidence: "high"
source: SEC EDGAR
---

# Teladoc Q2 revenue down 2% to $642.4M; net loss $837.7M on $790M goodwill impairment; FY outlook withdrawn

## Summary
- Q2 revenue $642.4M (-2% YoY); net loss $837.7M ($4.92/sh) includes $790M goodwill impairment for BetterHelp.
- Adjusted EBITDA $89.5M (+24% YoY); Integrated Care +5% to $377.4M, BetterHelp -9% to $265.0M.
- Company withdraws FY2024 consolidated and BetterHelp outlook and three-year outlook; provides Integrated Care guidance only.
- New CEO Chuck Divita joined; comments on strengthening execution and streamlining organization.
- Cash from operations $88.7M; free cash flow $60.9M; capex $27.7M.

## SEC filing metadata
- accession: 0001477449-24-000172
- form_type: 8-K
- ticker: TDOC
- cik: 0001477449
- company_name: Teladoc Health, Inc.
- filed_at: 2024-07-31T23:59:59+00:00
- event_type: earnings
- sentiment: negative
- materiality_score: 0.85
- calibrated_materiality_score: 0.85
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1477449/000147744924000172/0001477449-24-000172-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1477449/000147744924000172/tdoc-20240731.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001477449-24-000172
- JSON: https://secwatch.observer/filing/0001477449-24-000172.json
- Plain text: https://secwatch.observer/filing/0001477449-24-000172.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.